Showing results (1-10 of 354) with videos related to
Sort By:
Pageof 36
International Journal of Cardiology|August 18, 2016
Oral anticoagulation in octogenarians with atrial fibrillationGonzález Saldivar Hugo, Lourdes M Figueiras-Graillet, Manuel Anguita, et al.Journal of Cardiovascular Pharmacology and Therapeutics|August 1, 2015
Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA StudyJosé Moreno-Arribas, Vicente Bertomeu-González, Manuel Anguita-Sanchez, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 30, 2017
Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA RegistryMartín Ruiz Ortiz, Javier Muñiz, Paula Raña Míguez, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 2, 2020
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA StudyMartín Ruiz Ortiz, Javier Muñiz, María Asunción Esteve-Pastor, et al.Revista Espanola De Cardiologia (English Ed.)|June 22, 2015
Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA RegistryInmaculada Roldán Rabadán, Manuel Anguita Sánchez, Francisco Marín, et al.Revista Espanola De Cardiologia (English Ed.)|June 5, 2019
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA studyManuel Anguita Sánchez, Vicente Bertomeu Martínez, Martín Ruiz Ortiz, et al.Medicina Clinica|June 4, 2025
Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registriesJosé Miguel Rivera-Caravaca, Danilo Menichelli, Daniele Pastori, et al.Thrombosis Research|February 10, 2019
High and low on-treatment platelet reactivity to P2Y<sub>12</sub> inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary interventionJosé Luis Ferreiro, David Vivas, Jesús María De La Hera, et al.Frontiers in Cardiovascular Medicine|May 19, 2022
Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA RegistryMaría Asunción Esteve-Pastor, Martín Ruiz-Ortiz, Javier Muñiz, et al.Revista Espanola De Cardiologia (English Ed.)|July 23, 2020
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of CardiologyDavid Vivas, Vanessa Roldán, María Asunción Esteve-Pastor, et al.Pageof 36